Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K

Citius Pharmaceuticals reports 2019 executive compensation

By ExecPay News

Published: December 20, 2019

Citius Pharmaceuticals reported fiscal year 2019 executive compensation information on December 20, 2019.
In 2019, three executives at Citius Pharmaceuticals received on average a compensation package of $588K, a 15% increase compared to previous year.
Average pay of disclosed executives at Citius Pharmaceuticals
Myron Holubiak, Chief Executive Officer, received $764K in total, which increased by 12% compared to 2018. 59% of Holubiak's compensation, or $450K, was in salary. Holubiak also received $205K in non-equity incentive plan and $109K in option awards.
Jaime Bartushak, Chief Financial Officer, received a compensation package of $526K, which increased by 14% compared to previous year. 55% of the compensation package, or $290K, was in salary.
Leonard Mazur, Chairman, earned $473K in 2019, a 19% increase compared to previous year.
Citius Pharmaceuticals' fiscal year ends on September 30.

Related executives

Leonard Mazur

Citius Pharmaceuticals

Chief Executive Officer

Myron Holubiak

Citius Pharmaceuticals

Chairman

Jaime Bartushak

Citius Pharmaceuticals

Chief Financial Officer

You may also like

Source: SEC filing on December 20, 2019.